Rosoxacin in the therapy of uncomplicated gonorrhea. 1984

B Romanowski, and T W Austin, and F L Pattison, and D Lawee, and D Portnoy, and K F Givan, and E L Li, and K B Nguyen

In this randomized, multicentered study, 157 males and 130 females with laboratory-confirmed, uncomplicated anogenital Neisseria gonorrhoeae infections were evaluated to determine the efficacy and safety of a single 300-mg oral dose of rosoxacin versus 3.5 g of ampicillin plus 1 g of probenecid. A total of 130 males and 101 females were evaluated. Rosoxacin cured 90.3% (P = 0.053) and 94.1% (P = 0.62), respectively, whereas ampicillin was effective in 98.5 and 98% of males and females, respectively. All 39 patients with anorectal infections were cured. One penicillinase-producing N. gonorrhoeae strain was isolated and was eradicated with rosoxacin. Of 212 pretreatment isolates tested, 201 were inhibited by 0.06 micrograms or less of rosoxacin per ml. The MICs of rosoxacin for the remaining 11 isolates ranged up to 0.5 micrograms/ml. The incidence of adverse effects was relatively high (29% for the rosoxacin group versus 18% for the ampicillin group), but none of the reactions required medical intervention nor did they result in serious sequelae.

UI MeSH Term Description Entries
D008297 Male Males
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009344 Neisseria gonorrhoeae A species of gram-negative, aerobic bacteria primarily found in purulent venereal discharges. It is the causative agent of GONORRHEA. Diplococcus gonorrhoeae,Gonococcus,Gonococcus neisseri,Merismopedia gonorrhoeae,Micrococcus der gonorrhoe,Micrococcus gonococcus,Micrococcus gonorrhoeae
D010614 Pharynx A funnel-shaped fibromuscular tube that conducts food to the ESOPHAGUS, and air to the LARYNX and LUNGS. It is located posterior to the NASAL CAVITY; ORAL CAVITY; and LARYNX, and extends from the SKULL BASE to the inferior border of the CRICOID CARTILAGE anteriorly and to the inferior border of the C6 vertebra posteriorly. It is divided into the NASOPHARYNX; OROPHARYNX; and HYPOPHARYNX (laryngopharynx). Throat,Pharynxs,Throats
D011339 Probenecid The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy. Benecid,Benemid,Benuryl,Pro-Cid,Probecid,Probenecid Weimer
D011804 Quinolines
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females
D006069 Gonorrhea Acute infectious disease characterized by primary invasion of the urogenital tract. The etiologic agent, NEISSERIA GONORRHOEAE, was isolated by Neisser in 1879. Neisseria gonorrhoeae Infection

Related Publications

B Romanowski, and T W Austin, and F L Pattison, and D Lawee, and D Portnoy, and K F Givan, and E L Li, and K B Nguyen
December 1983, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
B Romanowski, and T W Austin, and F L Pattison, and D Lawee, and D Portnoy, and K F Givan, and E L Li, and K B Nguyen
November 1981, Antimicrobial agents and chemotherapy,
B Romanowski, and T W Austin, and F L Pattison, and D Lawee, and D Portnoy, and K F Givan, and E L Li, and K B Nguyen
November 1982, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
B Romanowski, and T W Austin, and F L Pattison, and D Lawee, and D Portnoy, and K F Givan, and E L Li, and K B Nguyen
January 1984, Sexually transmitted diseases,
B Romanowski, and T W Austin, and F L Pattison, and D Lawee, and D Portnoy, and K F Givan, and E L Li, and K B Nguyen
September 1986, Antimicrobial agents and chemotherapy,
B Romanowski, and T W Austin, and F L Pattison, and D Lawee, and D Portnoy, and K F Givan, and E L Li, and K B Nguyen
September 1971, Lakartidningen,
B Romanowski, and T W Austin, and F L Pattison, and D Lawee, and D Portnoy, and K F Givan, and E L Li, and K B Nguyen
July 1985, Deutsche medizinische Wochenschrift (1946),
B Romanowski, and T W Austin, and F L Pattison, and D Lawee, and D Portnoy, and K F Givan, and E L Li, and K B Nguyen
August 1984, The British journal of venereal diseases,
B Romanowski, and T W Austin, and F L Pattison, and D Lawee, and D Portnoy, and K F Givan, and E L Li, and K B Nguyen
October 1990, Journal of postgraduate medicine,
B Romanowski, and T W Austin, and F L Pattison, and D Lawee, and D Portnoy, and K F Givan, and E L Li, and K B Nguyen
June 1984, The British journal of venereal diseases,
Copied contents to your clipboard!